Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Carcinoma, Hepatocellular × MEK inhibitor I × Clear all

Sponsor

Interventions

Sorafenib 5 lenvatinib 2 cabozantinib 2 Nivolumab 2 Ipilimumab 2 tremelimumab 1 sacituzumab govitecan 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 Ramucirumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡